The Legal 500 > Advokatfirmaet Grette AS > Oslo, NORWAY > Press Releases > Grette ranked as Norway's best patent litigation firm

Advokatfirmaet Grette AS

FILIPSTAD BRYGGE 2, PO BOX 1397 VIKA, 0114 OSLO, NORWAY

Tel:: Work +47 22 34 00 00
Fax:: Fax +47 22 34 00 01

Email:

Web:: www.grette.no

Show all Press releases

Grette ranked as Norway's best patent litigation firm

July 2011

In the latest issue of IAM Patent Litigation 250, Grette is ranked as number one within patent litigation in Norway.

IAM says this about the firm and its attorneys with special competence in the field:
"This general business law outfit "has a long history as a very strong patent litigation firm" and delivers an "excellent and responsive" service to its clients. The firm represented MSD Norge, a subsidiary of Merck & Co, in a case regarding osteoporosis drug Fosamax. In addition, it has worked with BioMar and Novartis International. Managing partner Svein Ruud Johansen has expertise across the IP spectrum, specialising in pharmaceuticals and construction, and is commended for his "excellent courtroom presentation skills". Winning praise for his "superb legal analysis", multi-lingual practitioner Amund Brede Svendsen is popular with clients and colleagues and is highly experienced in the patent field."

For more information please visit www.grette.no

Search News and Articles

Legal Developments by:
Advokatfirmaet Grette AS

Proposed ban on personal import of medicinal products ordered via Internet

The Ministry of Health and Care has recently issued a hearing letter proposing stringent restrictions on import of medicinal products for personal use. Among the actions proposed, is a general ban on the import of prescription drugs, and access for Customs to seize and destroy falsified or illegal medicinal products.

- Advokatfirmaet Grette DA

Legal Developments in Norway

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to

Norway not included when short sale regulations in EU take effect 1 November 2012

From 1 November 2012 EU Regulation 236/2012 on short selling and certain aspects of credit default swaps will come into effect. Although the Regulation is within the scope of the EEA Agreement, Norway has not implemented the EU Regulation. Based on unofficial information from the Norwegian authorities, we expect the implementation process to be delayed until at least late 2013. Meanwhile, existing rules on short sale in Norway will continue to apply for transactions performed on the Norwegian market.

- Kluge Advokatfirma DA
Proposed ban on personal import of medicinal products ordered via Internet

The Ministry of Health and Care has recently issued a hearing letter proposing stringent restrictions on import of medicinal products for personal use. Among the actions proposed, is a general ban on the import of prescription drugs, and access for Customs to seize and destroy falsified or illegal medicinal products.

- Advokatfirmaet Grette DA
Increased transparency for applications for marketing authorisation

On 17th July 2012, the Norwegian Medicines Agency (NMA) announced a change in their practice regarding disclosure of information for applications of marketing authorisations for medicinal products.

- Advokatfirmaet Grette DA
New Patent Office Act to enter into effect on 1st January 2013

A new Act on the Patent Office and Industrial Property Rights Appeals Commission (the Patent Office Act) will be enacted and come into effect on 1st January 2013. The current Act on the Industrial Property Protection Board was enacted in 1910, and time for a complete reform had come.

- Advokatfirmaet Grette DA
Sunset clause for medicinal products in Norway

"Sunset clause" is a common term for the provision which could lead to the cessation of the validity of the marketing authorisation of a medicinal product.

- Advokatfirmaet Grette DA
New review on pension schemes

Questions on pensions have long had a large political focus in Norway, in connection with pension reforms such as obligatory occupational pension and changes in the National Insurance Scheme.

- Advokatfirmaet Grette DA
New provisions on competition clauses

In 2011 it was expected that new provisions for competition clauses, customer clauses and non-recruitment clauses would come into force. As early as June 2010, the Department of Employment sent a proposal on new provisions in the Working Environment Act for comments.

- Advokatfirmaet Grette DA
Norway implements the EU block exemption regulation for R&D agreements

Earlier this year, EU Commission Regulation No 1217/2010 was implemented in Norwegian law.

- Advokatfirmaet Grette DA
Hearing: Reimbursement of off-label use of medicinal products

In accordance with the provisions of the Act on Medicines and the appurtenant Regulation on Medicinal Products, pre-approved reimbursement for use of a medicinal product outside the approved indications of the marketing authorization is not allowed.

- Advokatfirmaet Grette DA
New review on pension schemes

Questions on pensions have long had a large political focus in Norway, in connection with pension reforms such as obligatory occupational pension and changes in the National Insurance Scheme.

- Advokatfirmaet Grette DA